| 2013 | | A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways. | 김유석, 임혜진, 정연훈 |
| 1999 | | A novel disintegrin salmosin inhibits tumor angiogenesis. | 이영돈 |
| 2016 | | A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis | 정성현 |
| 2015 | | A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient. | 박준성, 조성란, 한재호 |
| 2013 | | Actionable gene expression-based patient stratification for molecular targeted therapy in hepatocellular carcinoma. | 왕희정 |
| 2017 | | Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer | 강석윤, 김지훈, 노오규, 박래웅, 오영택, 윤덕용, 이현우, 전미선 |
| 2017 | | Altered intrinsic brain activity after chemotherapy in patients with gastric cancer: A preliminary study | 김현지 |
| 2024 | | An epidermal growth factor receptor-targeting immunotoxin based on IgG shows potent antitumor activity against head and neck cancer | 김철호, 이복순, 이윤상 |
| 2022 | | Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data | 강석윤, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
| 2019 | | Asian Society of Gynecologic Oncology International Workshop 2018 | 공태욱, 유희석, 장석준 |
| 2016 | | Attitudes toward participating in Phase I clinical trials: an investigation with patient-family-physician triads | 전미선 |
| 2013 | | AY4, an agonistic anti-death receptor 4 MAB, induces apoptotic cell death in anaplastic thyroid cancer cells via downregulation of Bcl-xL with reactive oxygen species generation. | 김철호, 신유섭, 이복순 |
| 2016 | | Bacterial production and structure-functional validation of a recombinant antigen-binding fragment (Fab) of an anti-cancer therapeutic antibody targeting epidermal growth factor receptor | 강호철, 박동선 |
| 2001 | | Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells. | 김승업, 최경숙 |
| 2012 | | Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma | 정현주 |
| 2015 | | By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, stichoposide D inhibits growth of leukemia xenografts. | 곽종영 |
| 2015 | | Ca2+ influx-mediated dilation of the endoplasmic reticulum and c-FLIPL downregulation trigger CDDO-Me-induced apoptosis in breast cancer cells. | 조혜성, 최경숙 |
| 2012 | | Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities | 정현주 |
| 2024 | | Cancer treatment-induced bone loss | 최용준 |
| 2009 | | Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence. | 윤계순 |
| 2005 | | Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis. | 최경숙 |
| 2024 | | Celecoxib and sulindac sulfide elicit anticancer effects on PIK3CA-mutated head and neck cancer cells through endoplasmic reticulum stress, reactive oxygen species, and mitochondrial dysfunction | 이상윤 |
| 2020 | | Cell cycle synchronisation using thiazolidinediones affects cellular glucose metabolism and enhances the therapeutic effect of 2-deoxyglucose in colon cancer | 박복남, 변혜은, 안영실, 윤준기, 이수진 |
| 2000 | | Chemotherapeutic drug, adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein-expressing liver cells. | 박선, 이재호, 조혜성 |
| 2016 | | Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer | 강석윤 |
| 2020 | | Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study | 박준은 |
| 2022 | | Clinical Characteristics and Treatment Outcomes of Childhood Acute Promyelocytic Leukemia in Korea: A Nationwide Multicenter Retrospective Study by Korean Pediatric Oncology Study Group | 최영배 |
| 2017 | | Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer | 노오규, 오영택, 장석준, 전미선, 조오연 |
| 2016 | | Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer | 백지흠 |
| 2015 | | Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia. | 강대용 |
| 2014 | | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial. | 강석윤 |
| 2020 | | Combination versus single-agent as palliative chemotherapy for gastric cancer | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2018 | | Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib | 박준성 |
| 1996 | | Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells. | 김진홍, 김효철, 이광재, 조성원, 함기백 |
| 2006 | | Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax. | 강석윤, 강승희, 김철호, 김효철, 박준성, 오영택, 이현우, 장준호, 전미선, 주희재, 최진혁, 한재호 |
| 2001 | | Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. | 서광욱 |
| 2005 | | Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). | 최경숙 |
| 2016 | | Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation | 정종철 |
| 2021 | | Determinants of quality of life in women immediately following the completion of primary treatment of breast cancer: A cross-sectional study | 김지영, 박진희, 배선형, 정용식 |
| 2016 | | Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas | 김성수, 서해영, 장다영 |
| 2022 | | Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors | 허훈 |
| 2017 | | Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer? | 최용원, 최진혁 |
| 2000 | | Dual anticancer activity of 8-Cl-cAMP: inhibition of cell proliferation and induction of apoptotic cell death. | 이명애 |
| 2014 | | Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors. | 박준성, 정성현 |
| 2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2010 | | Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. | 김철호, 이진석, 정연훈 |
| 2020 | | Evolution of Machine Learning Algorithms in the Prediction and Design of Anticancer Peptides | Balachandran, Manavalan, Basith, Shaherin, 신태환, 이광, 이다연 |
| 2016 | | Factors Influencing Posttraumatic Growth in Survivors of Breast Cancer | 박진희, 정용식 |
| 2018 | | Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study | 이현우 |
| 2017 | | Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results | 강석윤 |
| 2016 | | Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model | 손상용 |
